The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
Open accessAbstract
Multiple myeloma remains largely incurable. However, a few patients experience more than 10 years of relapse-free survival and can be considered as operationally cured. Interestingly, long-term disease control in multiple myeloma is not restricted to patients with a complete response, since some patients revert to having a profile of monoclonal gammopathy of undetermined significance. We compared the distribution of multiple compartments of lymphocytes and dendritic cells in the bone marrow and peripheral blood of multiple myeloma patients with long-term disease control (n=28), patients with newly diagnosed monoclonal gammopathy of undetermined significance (n=23), patients with symptomatic multiple myeloma (n=23), and age-matched healthy adults (n=10). Similarly to the patients with monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma, patients with long-term disease control showed an expansion of cytotoxic CD8(+) T cells and natural killer cells. However, the numbers of bone marrow T-regulatory cells were lower in patients with long-term disease control than in those with symptomatic multiple myeloma. It is noteworthy that B cells were depleted in patients with monoclonal gammopathy of undetermined significance and in those with symptomatic multiple myeloma, but recovered in both the bone marrow and peripheral blood of patients with long-term disease control, due to an increase in normal bone marrow B-cell precursors and plasma cells, as well as pre-germinal center peripheral blood B cells. The number of bone marrow dendritic cells and tissue macrophages differed significantly between patients with long-term disease control and those with symptomatic multiple myeloma, with a trend to cell count recovering in the former group of patients towards levels similar to those found in healthy adults. In summary, our results indicate that multiple myeloma patients with long-term disease control have a constellation of unique immune changes favoring both immune cytotoxicity and recovery of B-cell production and homing, suggesting improved immune surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“31 In our study, Treg cells were identified based on their unique CD4, CD25, CD127 phenotype (Figure 1A), which has been shown to be directly correlated to the major CD4, FoxP3 Treg subset.(32,33) It can, therefore, be hypothesized that in LTDC-MM patients, the reduction of R.”
BackgroundInfections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
Nucci, M., & Anaissie, E. (2009) · Clinical Infectious Diseases · doi:10.1086/605664 · Cited by 347
Self-citation
Cited by
Targeting the bone marrow microenvironment in multiple myeloma
Kawano, Y., Moschetta, M., Manier, S., Glavey, S., Görgün, G. T., Roccaro, A. M., Anderson, K. C., & Ghobrial, I. M. (2015) · Immunological Reviews · doi:10.1111/imr.12233 · Cited by 391
Zavidij, O., Haradhvala, N. J., Mouhieddine, T. H., Sklavenitis-Pistofidis, R., Cai, S., Reidy, M., Rahmat, M., Flaifel, A., Ferland, B., Su, N. K., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0053-3 · Cited by 374
Braga, W. M. T., da Silva, B. R., de Carvalho, A. C., Maekawa, Y. H., Bortoluzzo, A. B., Rizzatti, E. G., Atanackovic, D., & Colleoni, G. W. B. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1589-9 · Cited by 88
Metadata
- Authors
- Pessoa de Magalhaes, R. J., Vidriales, M.-B., Paiva, B., Fernandez-Gimenez, C., Garcia-Sanz, R., Mateos, M.-V., Gutierrez, N. C., Lecrevisse, Q., Blanco, J. F., Hernandez, J., de las Heras, N., Martinez-Lopez, J., Roig, M., Costa, E. S., Ocio, E. M., Perez-Andres, M., Maiolino, A., Nucci, M., De La Rubia, J., Lahuerta, J.-J., San-Miguel, J. F., Orfao, A., & the Spanish Myeloma Group (GEM) and Grupo Castellano-Leones de Gammapatias Monoclonales, C. S. G.
- Venue
- Haematologica
- Published
- 2012-07-06
- Volume
- 98
- Issue
- 1
- Pages
- 79-86
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2147423551
- Cited by
- 171
- References
- 3
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry. https://app.cochat.ai/papers/10.3324/haematol.2012.067272
- The paper
- Pessoa de Magalhaes, R. J., Vidriales, M.-B., Paiva, B., Fernandez-Gimenez, C., Garcia-Sanz, R., Mateos, M.-V., Gutierrez, N. C., Lecrevisse, Q., Blanco, J. F., Hernandez, J., de las Heras, N., Martinez-Lopez, J., Roig, M., Costa, E. S., Ocio, E. M., Perez-Andres, M., Maiolino, A., Nucci, M., De La Rubia, J., . . . the Spanish Myeloma Group (GEM) and Grupo Castellano-Leones de Gammapatias Monoclonales, C. S. G. (2013). Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry. Haematologica. https://doi.org/10.3324/haematol.2012.067272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.